| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2008 | US20080003225 Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors |
| 01/03/2008 | US20080003222 Inhibitors for L1 and Adam10 for the Treatment of Carcinomas |
| 01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
| 01/03/2008 | US20080003219 Delivery of an ocular agent |
| 01/03/2008 | US20080003217 Ilk inhibitors for the treatment of renal disease |
| 01/03/2008 | US20080003214 Medicaments Comprising Carbonyl Compounds, And The Use Thereof |
| 01/03/2008 | US20080003213 Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein, interleukin-6, or interferon-gamma levels |
| 01/03/2008 | US20080003209 Method for treatment of neurodegenerative diseases and the effects of aging |
| 01/03/2008 | US20080003208 Creatine-ligand compounds and methods of use thereof |
| 01/03/2008 | US20080003204 Compositions and methods for treating cystic fibrosis |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/03/2008 | US20080003196 Absorbable cyanoacrylate compositions |
| 01/03/2008 | US20080003195 Cosmetic composition comprising at least one vinyl polymer and at least one olefin copolymer |
| 01/03/2008 | US20080003191 Composition combining a C-glycoside derivative and an emulsifying polymer |
| 01/03/2008 | US20080003188 Composition and Method for Treating Keratosis Pilaris |
| 01/03/2008 | US20080003181 Treatment of depressive disorders |
| 01/03/2008 | DE10245212B4 Verwendung säurehaltiger Mittel zur Desensibilisierung von Zähnen Using acidic agent for desensitization of teeth |
| 01/03/2008 | DE102006031314A1 Use of 1,4-diaryl-dihydropyrimidin-2-one derivative for producing a medicament for the treatment and/or prophylaxis of e.g. pulmonary arterial hypertension, chronic-obstructive lung diseases and sleep apnea syndrome |
| 01/03/2008 | DE102006030416A1 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate 18-methyl-19-nor-androst-4-ene-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one), as well as pharmaceutical compositions containing them |
| 01/03/2008 | DE102006030366A1 Pharmaceutical composition useful for treating Parkinson's disease comprises a substance that specifically interacts with a homer1 gene |
| 01/03/2008 | DE102006030073A1 Lipstick, useful for the treatment of herpes, protection of lip from sunburn and for lip care |
| 01/03/2008 | DE102006030037A1 Oral product, useful for preventing and treating seborrheic dermatitis, comprises cobalamin and/or betaines |
| 01/03/2008 | DE102006030035A1 Topical product, useful for preventing and treating seborrheic dermatitis, comprises cobalamin and/or betaines |
| 01/03/2008 | DE102006030031A1 Feminine hygiene article, useful for the prevention and fight against candidiasis, comprises vitamin B12, vitamin B12 synthesis promoting substances, folic acid, vitamin B6, zinc oxides, cobalt, dimethylbenzimidazole and biotin |
| 01/03/2008 | DE102006029795A1 Neue Harnstoff-Derivate und deren Verwendungen New urea derivatives and their uses |
| 01/03/2008 | DE102006029500A1 Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin Use of an antimicrobial curing alginate for the topical treatment of wounds and inflammation in human medicine, dentistry and veterinary medicine |
| 01/03/2008 | DE102005061756B4 Verbessertes Verfahren zur Herstellung von Ramipril An improved process for the preparation of Ramipril |
| 01/03/2008 | CA2839595A1 Caspase-8 and inflammation, infection and wound healing |
| 01/03/2008 | CA2838448A1 Fused cyclic compounds |
| 01/03/2008 | CA2660782A1 Organic compounds |
| 01/03/2008 | CA2659762A1 Thiazoline and oxazoline derivatives and their methods of use |
| 01/03/2008 | CA2658362A1 Metalloprotease inhibitors |
| 01/03/2008 | CA2657973A1 Therapeutic compounds |
| 01/03/2008 | CA2657107A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2657096A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2656587A1 Tooth enamel dissolution inhibitor |
| 01/03/2008 | CA2656564A1 Biaryl compositions and methods for modulating a kinase cascade |
| 01/03/2008 | CA2656443A1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same |
| 01/03/2008 | CA2656438A1 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles |
| 01/03/2008 | CA2656320A1 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 01/03/2008 | CA2656277A1 Active agent formulations, methods of making, and methods of use |
| 01/03/2008 | CA2656271A1 An anti-viral composition for the topical treatment of herpes labialis (cold sores) and method for use thereof |
| 01/03/2008 | CA2656165A1 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2656150A1 New cxcr2 inhibitors |
| 01/03/2008 | CA2656107A1 Cancer therapy using bcl-xl-specific sina |
| 01/03/2008 | CA2656089A1 Substituted benzyl amine compounds |
| 01/03/2008 | CA2656083A1 Substituted aminomethyl benzamide compounds |
| 01/03/2008 | CA2656075A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | CA2656072A1 Substituted benzamide modulators of the histamine h3 receptor |
| 01/03/2008 | CA2656069A1 Pharmaceutical composition comprising tetrahydrolipstatin |
| 01/03/2008 | CA2656067A1 Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| 01/03/2008 | CA2656003A1 Fused cyclic compounds |
| 01/03/2008 | CA2655999A1 Treating agent of inflammatory bowel disease |
| 01/03/2008 | CA2655987A1 Adenosine a2a receptor antagonists |
| 01/03/2008 | CA2655937A1 C-phenyl 1-thioglucitol compound |
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/03/2008 | CA2655881A1 Crystalline forms of atorvastatin |
| 01/03/2008 | CA2655829A1 Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist |
| 01/03/2008 | CA2655828A1 Compositions and methods of treating cns disorders |
| 01/03/2008 | CA2655676A1 Phenylacetic acid derivatives |
| 01/03/2008 | CA2655615A1 A pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation |
| 01/03/2008 | CA2655568A1 Organic compounds |
| 01/03/2008 | CA2655546A1 Detection of esr1 amplification in breast cancer |
| 01/03/2008 | CA2655540A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 01/03/2008 | CA2655522A1 Use of defibrotide for the inhibition of heparanase |
| 01/03/2008 | CA2655444A1 New compounds 385 |
| 01/03/2008 | CA2655441A1 New compounds 384 |
| 01/03/2008 | CA2655398A1 4-amino-3-(3-azolyl-phenoxymethyl)-thieno[3,2-c]pyridine-7-carboxylic acid derivatives and uses thereof for treating cancer, atherosclerosis and restenosis |
| 01/03/2008 | CA2655397A1 Pyrimidine and quinazoline derivatives |
| 01/03/2008 | CA2655381A1 Compositions of glycopyrronium salt for inhalation |
| 01/03/2008 | CA2655233A1 Use of pkc inhibitors in diabetic complications |
| 01/03/2008 | CA2655228A1 New pyridine analogues |
| 01/03/2008 | CA2655159A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | CA2654986A1 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/03/2008 | CA2654945A1 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/03/2008 | CA2654936A1 Use of hdac inhibitors for the treatment of lymphomas |
| 01/03/2008 | CA2654915A1 Tetrazole-substituted arylamides |
| 01/03/2008 | CA2654852A1 Pyrimidine derivatives useful in the treatment of cancer |
| 01/03/2008 | CA2654801A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/03/2008 | CA2654798A1 Flibanserin for the treatment of urinary incontinence and related diseases |
| 01/03/2008 | CA2654652A1 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | CA2654650A1 Organic compounds |
| 01/03/2008 | CA2654506A1 Antimicrobial articles comprising quaternary ammonium capped polymers |
| 01/03/2008 | CA2654394A1 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 01/03/2008 | CA2654375A1 Therapeutic compounds |
| 01/03/2008 | CA2654371A1 Therapeutic compounds |
| 01/03/2008 | CA2654264A1 Inhalant powder containing phenylalanine |
| 01/03/2008 | CA2654255A1 Compositions with several hyaluronic acid fractions for cosmetic and medical uses |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | CA2653726A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | CA2653569A1 S1p receptor modulators for treating multiple sclerosis |
| 01/03/2008 | CA2653384A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | CA2653382A1 A stabilised composition comprising ace inhibitors |
| 01/03/2008 | CA2653344A1 Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl)methyl)phenyl-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 01/03/2008 | CA2652852A1 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 01/03/2008 | CA2652811A1 Potentiator of radiation therapy |
| 01/03/2008 | CA2652226A1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 01/03/2008 | CA2648769A1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | CA2647601A1 Pyrrole derivatives and their methods of use |